Free tool

Diagnostics stocks

We cover 13 companies grouped under the Diagnostics theme. The median market value in the group is $298.43M. Across the group, the median move over the past trading day is −0.99%. Price change over the past year runs from −47.2% to +69.3% across the middle 80 percent of the group, with a median of +6.3%.

Other lists in this group

Table

13 of 150 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
PSNLPersonalis, Inc.$1.82BSmall cap+257.32%
OPKOPKO Health, Inc.$1.11BSmall cap+6.34%
CSTLCastle Biosciences, Inc.$1.04BSmall cap+52.96%
QDELQuidelOrtho Corporation$1.02BSmall cap−46.31%
FLGTFulgent Genetics, Inc.$545.08MSmall cap−8.46%
NNNNAnbio Biotechnology$343.67MSmall cap−83.55%
MYGNMyriad Genetics, Inc.$298.43MSmall cap−47.39%
OSUROraSure Technologies, Inc.$255.87MSmall cap+11.08%
LUCDLucid Diagnostics Inc.$185.35MSmall cap−22.96%
IMDXInsight Molecular Diagnostics Inc.$145.30MSmall cap+73.39%
PCSCPerceptive Capital Solutions Corp$123.25MSmall cap+13.38%
QUCYQuantum Cyber N.V.$115.59MSmall cap−15.12%
BNRBurning Rock Biotech Limited$110.10MSmall cap+22.54%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse